T cell responses after yellow fever and other vaccinations

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034356

Enrollment

200

Registered

2024-05-29

Start date

2021-03-15

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z23 Z24 Z25

Interventions

Group 1: Healthy donors who have received a vaccination in the vaccination and travel consultation hours of the University Hospital Erlangen at the Institute of Microbiology. During the vaccination in

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Vaccination with the vaccine for which the immune responses is to be investigated

Exclusion criteria

Exclusion criteria: a) Incapable of giving consent b) Minors c) Pregnant or breastfeeding women d) Persons who are in a dependent relationship with other study participants or the study investigators

Design outcomes

Primary

Measure	Time frame
Antigen specificity (determined based on the binding of pMHC multimers), RNA transcriptome, T cell receptor sequence, HLA status	—

Secondary

Measure	Time frame
Antigen-specific T cell response size	—

Countries

Germany

Contacts

Public ContactKilian Schober

Universitätsklinikum Erlangen

kilian.schober@uk-erlangen.de+4991318532644

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026